GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mydecine Innovations Group Inc (AQSE:MYIG) » Definitions » ROE % Adjusted to Book Value

Mydecine Innovations Group (AQSE:MYIG) ROE % Adjusted to Book Value : 0.00% (As of Sep. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Mydecine Innovations Group ROE % Adjusted to Book Value?

Mydecine Innovations Group's ROE % for the quarter that ended in Sep. 2023 was 0.00%. Mydecine Innovations Group's PB Ratio for the quarter that ended in Sep. 2023 was N/A. Mydecine Innovations Group's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2023 was N/A.


Mydecine Innovations Group ROE % Adjusted to Book Value Historical Data

The historical data trend for Mydecine Innovations Group's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mydecine Innovations Group ROE % Adjusted to Book Value Chart

Mydecine Innovations Group Annual Data
Trend Dec13 Aug14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Mydecine Innovations Group Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - Negative Equity - - -

Competitive Comparison of Mydecine Innovations Group's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Mydecine Innovations Group's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mydecine Innovations Group's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mydecine Innovations Group's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Mydecine Innovations Group's ROE % Adjusted to Book Value falls into.



Mydecine Innovations Group ROE % Adjusted to Book Value Calculation

Mydecine Innovations Group's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Mydecine Innovations Group's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mydecine Innovations Group ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Mydecine Innovations Group's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Mydecine Innovations Group (AQSE:MYIG) Business Description

Traded in Other Exchanges
Address
789 West Pender Street, Suite 810, Vancouver, BC, CAN, V6C 1H2
Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.

Mydecine Innovations Group (AQSE:MYIG) Headlines

No Headlines